GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kadimastem Ltd (XTAE:KDST) » Definitions » 3-Year EBITDA Growth Rate

Kadimastem (XTAE:KDST) 3-Year EBITDA Growth Rate : 44.30% (As of Jun. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Kadimastem 3-Year EBITDA Growth Rate?

Kadimastem's EBITDA per Share for the six months ended in Jun. 2024 was ₪-0.36.

During the past 3 years, the average EBITDA Per Share Growth Rate was 44.30% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 40.50% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 26.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 11 years, the highest 3-Year average EBITDA Per Share Growth Rate of Kadimastem was 46.20% per year. The lowest was -33.70% per year. And the median was 35.35% per year.


Competitive Comparison of Kadimastem's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Kadimastem's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kadimastem's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kadimastem's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Kadimastem's 3-Year EBITDA Growth Rate falls into.



Kadimastem 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Kadimastem  (XTAE:KDST) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Kadimastem 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Kadimastem's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Kadimastem Business Description

Traded in Other Exchanges
N/A
Address
Pinchas Sapir 7, Weizmann Science Park, Nes-Ziona, ISR
Kadimastem Ltd is a biopharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from Human Embryonic Stem Cells (hESCs) to treat neuro-degenerative diseases such as ALS and Diabetes. It is developing revolutionary regenerative therapies based on stem cells.

Kadimastem Headlines

No Headlines